GG 931 (Orphenadrine Citrate Extended-Release 100 mg)

Pill imprint GG 931 has been identified as Orphenadrine citrate extended-release 100 mg.

Orphenadrine is used in the treatment of muscle spasm; migraine and belongs to the drug class skeletal muscle relaxants. Risk cannot be ruled out during pregnancy. Orphenadrine 100 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for GG 931 (Orphenadrine Citrate Extended-Release 100 mg)

Orphenadrine citrate extended-release 100 mg GG 931
Orphenadrine citrate extended-release
GG 931
100 mg
Prescription only
Drug Class:
Skeletal muscle relaxants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
43386-0480 Gavis Pharmaceuticals
55045-1325 Dispensing Solutions Inc. (repackager)
57866-7601 Direct Dispensing Inc (repackager)
10544-0359 Blenheim Pharmacal Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)